• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便微生物移植在感染后模型中有效缓解内脏敏感性。

Fecal Microbiota Transplantation Is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model.

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.

出版信息

Biomed Res Int. 2018 Jan 30;2018:3860743. doi: 10.1155/2018/3860743. eCollection 2018.

DOI:10.1155/2018/3860743
PMID:29992140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5833243/
Abstract

AIM

To investigate the effect of fecal microbiota transplantation on visceral hypersensitivity compared with .

METHODS

Mice visceral hypersensitivity was induced by . After 8 weeks, they were divided into three groups (controls, , and fecal microbiota transplantation) and were daily treated by gavage with 0.2 ml PBS, HB55020, or fecal microbiota for 7 days. Visceral hypersensitivity was tested with abdominal withdrawal reflex. Permeability of colon epithelium was assessed with Ussing chamber.

RESULTS

After administration of , compared with mice in postinfectious group, mice had higher pain threshold ( < 0.05). After administration of fecal microbiota, compared with mice in postinfectious group, mice had higher pain threshold ( < 0.05). Fecal microbiota transplantation was as effective as in relieving visceral hypersensitivity. Administration of or fecal microbiota transplantation improved colon epithelium permeability. Expression of occluding-1 was increased.

CONCLUSION

Manipulation of microbiota is effective in relieving visceral hypersensitivity. Fecal microbiota transplantation is as effective as administration.

摘要

目的

与 相比,研究粪便微生物群移植对内脏敏感性的影响。

方法

通过 诱导小鼠内脏敏感性。8 周后,将其分为三组(对照组、 和粪便微生物群移植组),并每天通过灌胃给予 0.2ml PBS、HB55020 或粪便微生物群 7 天。通过腹壁退缩反射测试内脏敏感性。使用 Ussing 室评估结肠上皮通透性。

结果

给予 后,与感染后组相比,疼痛阈值较高(<0.05)。给予粪便微生物群后,与感染后组相比,疼痛阈值较高(<0.05)。粪便微生物群移植与 一样有效缓解内脏敏感性。给予 或粪便微生物群移植可改善结肠上皮通透性。occluding-1 的表达增加。

结论

微生物群的操纵在缓解内脏敏感性方面是有效的。粪便微生物群移植与 给药一样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/cdb1ad8510d2/BMRI2018-3860743.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/fbd6d89372c5/BMRI2018-3860743.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/9a8efb7589a2/BMRI2018-3860743.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/cdb1ad8510d2/BMRI2018-3860743.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/fbd6d89372c5/BMRI2018-3860743.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/9a8efb7589a2/BMRI2018-3860743.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/5833243/cdb1ad8510d2/BMRI2018-3860743.003.jpg

相似文献

1
Fecal Microbiota Transplantation Is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model.粪便微生物移植在感染后模型中有效缓解内脏敏感性。
Biomed Res Int. 2018 Jan 30;2018:3860743. doi: 10.1155/2018/3860743. eCollection 2018.
2
The prolonged disruption of a single-course amoxicillin on mice gut microbiota and resistome, and recovery by inulin, Bifidobacterium longum and fecal microbiota transplantation.阿莫西林单疗程给药对小鼠肠道微生物群和耐药组的长期破坏,以及菊粉、长双歧杆菌和粪便微生物群移植的恢复作用。
Environ Pollut. 2020 Oct;265(Pt A):114651. doi: 10.1016/j.envpol.2020.114651. Epub 2020 Apr 23.
3
Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.利福昔明对感染后肠易激综合征小鼠模型的有益作用超出了肠道微生物群。
J Gastroenterol Hepatol. 2018 Feb;33(2):443-452. doi: 10.1111/jgh.13841.
4
Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome.NLRP3 炎性小体在长双歧杆菌调节感染后肠易激综合征内脏敏感性中的作用。
Artif Cells Nanomed Biotechnol. 2016 Dec;44(8):1933-1937. doi: 10.3109/21691401.2015.1111238. Epub 2015 Dec 24.
5
Effects of Queso Blanco cheese containing Bifidobacterium longum KACC 91563 on fecal microbiota, metabolite and serum cytokine in healthy beagle dogs.含长双歧杆菌 KACC 91563 的白奶酪对健康比格犬粪便微生物群、代谢物和血清细胞因子的影响。
Anaerobe. 2020 Aug;64:102234. doi: 10.1016/j.anaerobe.2020.102234. Epub 2020 Jul 3.
6
Different Alterations in Gut Microbiota between and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism.自闭症丙酸血症大鼠模型中,肠道微生物群和粪便微生物群移植治疗的不同改变。
Nutrients. 2022 Jan 30;14(3):608. doi: 10.3390/nu14030608.
7
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.富含双歧杆菌的粪便供体可能是肠易激综合征患者粪便微生物群移植成功的一个积极预测指标。
Digestion. 2017;96(1):29-38. doi: 10.1159/000471919. Epub 2017 Jun 21.
8
Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.蛋白酶激活受体-2 在感染后肠易激综合征小鼠中诱导免疫激活和内脏敏感性。
Dig Dis Sci. 2019 Mar;64(3):729-739. doi: 10.1007/s10620-018-5367-y. Epub 2018 Nov 16.
9
Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species.婴儿粪便微生物群的非培养分析,特别关注双歧杆菌属。
FEMS Microbiol Lett. 2005 Feb 15;243(2):417-23. doi: 10.1016/j.femsle.2005.01.002.
10
Bifidobacterium longum and VSL#3 amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment.长双歧杆菌和VSL#3对三硝基苯磺酸诱导的结肠炎的改善作用与高迁移率族蛋白B1减少及上皮屏障损伤减轻相关。
Dev Comp Immunol. 2019 Mar;92:77-86. doi: 10.1016/j.dci.2018.09.006. Epub 2018 Sep 15.

引用本文的文献

1
Microbiome contributions to pain: a review of the preclinical literature.微生物群对疼痛的影响:临床前文献综述
Pain. 2025 Feb 1;166(2):262-281. doi: 10.1097/j.pain.0000000000003376. Epub 2024 Sep 10.
2
Pathology of pain and its implications for therapeutic interventions.疼痛的病理学及其对治疗干预的影响。
Signal Transduct Target Ther. 2024 Jun 8;9(1):155. doi: 10.1038/s41392-024-01845-w.
3
Role of in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives.[具体物质]在调节肠道上皮紧密连接屏障中的作用:当前的认识与展望

本文引用的文献

1
The gut microbiota as a key regulator of visceral pain.肠道微生物群作为内脏痛的关键调节因子。
Pain. 2017 Apr;158 Suppl 1:S19-S28. doi: 10.1097/j.pain.0000000000000779.
2
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.粪便过滤移植治疗艰难梭菌感染的疗效。
Gastroenterology. 2017 Mar;152(4):799-811.e7. doi: 10.1053/j.gastro.2016.11.010. Epub 2016 Nov 17.
3
Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™.
Curr Dev Nutr. 2023 Oct 30;7(12):102026. doi: 10.1016/j.cdnut.2023.102026. eCollection 2023 Dec.
4
Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive review.肠道-脑轴调节与肠易激综合征进展之间相互作用过程中的分子信号传导:综述
World J Clin Cases. 2023 Jul 6;11(19):4458-4476. doi: 10.12998/wjcc.v11.i19.4458.
5
Use of dexmedetomidine to alleviate intestinal ischemia-reperfusion injury via intestinal microbiota modulation in mice.使用右美托咪定通过调节小鼠肠道微生物群来减轻肠道缺血再灌注损伤。
Ann Transl Med. 2022 Nov;10(21):1161. doi: 10.21037/atm-22-824.
6
Pain after upper limb surgery under peripheral nerve block is associated with gut microbiome composition and diversity.上肢手术在周围神经阻滞下出现的疼痛与肠道微生物群的组成和多样性有关。
Neurobiol Pain. 2021 Aug 18;10:100072. doi: 10.1016/j.ynpai.2021.100072. eCollection 2021 Aug-Dec.
7
Animal models of visceral pain and the role of the microbiome.内脏痛的动物模型与微生物组的作用。
Neurobiol Pain. 2021 May 28;10:100064. doi: 10.1016/j.ynpai.2021.100064. eCollection 2021 Aug-Dec.
8
Post-infection Irritable Bowel Syndrome.感染后肠易激综合征。
Gastroenterol Clin North Am. 2021 Jun;50(2):445-461. doi: 10.1016/j.gtc.2021.02.007. Epub 2021 Apr 23.
9
alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation.通过对潘氏细胞的调节,减轻肠易激综合征相关内脏敏感性和微生物失调。
Gut Microbes. 2020 Nov 9;12(1):1782156. doi: 10.1080/19490976.2020.1782156. Epub 2020 Jun 25.
10
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome.肠道真菌群在肠易激综合征中的潜在作用
Front Microbiol. 2019 Aug 21;10:1894. doi: 10.3389/fmicb.2019.01894. eCollection 2019.
长双歧杆菌亚种长双歧杆菌35624™产生的胞外多糖的基因组分析与表征
PLoS One. 2016 Sep 22;11(9):e0162983. doi: 10.1371/journal.pone.0162983. eCollection 2016.
4
Revised Estimates for the Number of Human and Bacteria Cells in the Body.人体和细菌细胞数量的修订估计值。
PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. eCollection 2016 Aug.
5
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.内脏高敏感性在肠易激综合征中的作用:药理学靶点与新疗法
J Neurogastroenterol Motil. 2016 Oct 30;22(4):558-574. doi: 10.5056/jnm16001.
6
The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?丁酸盐的神经药理学:微生物群-肠-脑轴的关键所在?
Neurochem Int. 2016 Oct;99:110-132. doi: 10.1016/j.neuint.2016.06.011. Epub 2016 Jun 23.
7
Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.益生菌类型、剂量和治疗持续时间对罗马III标准诊断的肠易激综合征的影响:一项荟萃分析。
BMC Gastroenterol. 2016 Jun 13;16(1):62. doi: 10.1186/s12876-016-0470-z.
8
Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.应激与内脏痛中的微生物群-肠-脑轴:与肠易激综合征的相关性
CNS Neurosci Ther. 2016 Feb;22(2):102-17. doi: 10.1111/cns.12490. Epub 2015 Dec 10.
9
Visceral Pain and Psychiatric Disorders.内脏疼痛与精神疾病
Mod Trends Pharmacopsychiatry. 2015;30:103-19. doi: 10.1159/000435936. Epub 2015 Sep 18.
10
Specialized metabolites from the microbiome in health and disease.健康与疾病中微生物组产生的特殊代谢产物。
Cell Metab. 2014 Nov 4;20(5):719-730. doi: 10.1016/j.cmet.2014.10.016.